Overview

Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of Ramipril 10 mg capsule (test) versus AltaceĀ® (reference), administered as 1 x 10 mg capsule under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Teva Pharmaceuticals USA
Treatments:
Ramipril